Home/Filings/4/0001127602-11-025591
4//SEC Filing

RICH ALEXANDER 4

Accession 0001127602-11-025591

CIK 0000874663other

Filed

Sep 19, 8:00 PM ET

Accepted

Sep 20, 1:12 PM ET

Size

23.6 KB

Accession

0001127602-11-025591

Insider Transaction Report

Form 4
Period: 2011-09-16
Transactions
  • Disposition to Issuer

    Non Qualified Stock Option (Right to Buy)

    2011-09-1620,0000 total
    Exercise: $7.19Exp: 2012-09-18Common Stock (20,000 underlying)
  • Disposition to Issuer

    Common Stock

    2011-09-16348,4000 total
  • Disposition to Issuer

    Non Qualified Stock Option (Right to Buy)

    2011-09-1620,0000 total
    Exercise: $13.44Exp: 2013-09-09Common Stock (20,000 underlying)
  • Disposition to Issuer

    Non Qualified Stock Option (Right to Buy)

    2011-09-1620,0000 total
    Exercise: $11.84Exp: 2014-09-23Common Stock (20,000 underlying)
  • Disposition to Issuer

    Non Qualified Stock Option (Right to Buy)

    2011-09-1620,0000 total
    Exercise: $16.77Exp: 2015-09-23Common Stock (20,000 underlying)
  • Disposition to Issuer

    Non Qualified Stock Option (Right to Buy)

    2011-09-1620,0000 total
    Exercise: $14.04Exp: 2016-09-21Common Stock (20,000 underlying)
  • Disposition to Issuer

    Non Qualified Stock Option (Right to Buy)

    2011-09-1620,0000 total
    Exercise: $18.29Exp: 2017-10-09Common Stock (20,000 underlying)
  • Disposition to Issuer

    Non Qualified Stock Option (Right to Buy)

    2011-09-1620,0000 total
    Exercise: $11.44Exp: 2018-10-07Common Stock (20,000 underlying)
  • Disposition to Issuer

    Non Qualified Stock Option (Right to Buy)

    2011-09-1620,0000 total
    Exercise: $8.98Exp: 2019-10-06Common Stock (20,000 underlying)
  • Disposition to Issuer

    Non Qualified Stock Option (Right to Buy)

    2011-09-1620,0000 total
    Exercise: $14.92Exp: 2020-10-05Common Stock (20,000 underlying)
Footnotes (3)
  • [F1]Disposition made in connection with the conversion of shares pursuant to the merger of Alkermes, Inc. and the global drug delivery technologies business of Elan (the "Merger") into an equal number of ordinary shares of Alkermes plc having a market value, based on the closing price on the effective date of the Merger, of $16.57 per share.
  • [F2]These options are fully vested in accordance with their terms.
  • [F3]Options assumed/converted in the Merger into the right to buy the same number of ordinary shares of Alkermes plc on substantially the same terms.

Issuer

ALKERMES INC

CIK 0000874663

Entity typeother

Related Parties

1
  • filerCIK 0001236445

Filing Metadata

Form type
4
Filed
Sep 19, 8:00 PM ET
Accepted
Sep 20, 1:12 PM ET
Size
23.6 KB